Asma El Sony, Ph.D., president, The Union, addresses the attributes of DOTS and why health care systems in developing nations should integrate the care of different diseases.

Kenneth Castro, M.D., director, Division of TB Elimination, U.S. Centers for Disease Control and Prevention talks about the factors contributing to XDR-TB and the development of new medicines to treat drug resistant TB.

Richard O'Brien, M.D., head of Scientific Evaluation, Foundation for New Diagnostics talks about the need for new tools to diagnose, treat and prevent TB.

Gareth Thomas, member of Parliament and the U.K.'s International Development Minister, addresses how developed nations can help prevent health care workers from leaving developing countries and corporate responsibility in the fight against TB. 

HIV/AIDS and TB activist Winstone Zulu emphasizes the importance of treating HIV and TB together and why eliminating TB stigma is essential.

Nils Billo, M.D., M.P.H., executive director of the The Union, addresses how to increase awareness of TB issues and success stories from The Union's work in high-burden countries.

George Soros, founder and chairman of the Open Society Institute, and researchers Olayide Akanni and Afsan Chowdhury, discuss Public Health Watch's new report, "Civil Society Perspectives on TB Policy in Bangladesh, Brazil, Nigeria, Tanzania, and Thailand."

Mario Raviglione, M.D., director of the WHO's Stop TB Department, assesses the Global Plan to Stop TB launch and how the emergence of XDR-TB has changed the way he does his job.